About this trial
A specific tool developed to measure self-care in patients with Idiopathic Pulmonary Fibrosis (IPF) is the SC-IPFI, which is an adaptation of an already validated instrument for COPD. It is important to assess how motivational interviewing can influence the self-care behaviors of these patients, better evaluate their level of disease management, prevent the risk of exacerbations, and guide educational interventions.
The primary objective of this study is to evaluate the effectiveness of a motivational interviewing program delivered remotely through video calls and digital platforms in improving the levels of self-care maintenance, self-care monitoring, and self-care management in patients with IPF. The study will also assess the effectiveness of the remotely delivered motivational interviewing program on self-efficacy, anxiety, disease-specific quality of life, therapy adherence, cough, dyspnea, exacerbations, and hospital admissions.
Eligibility criteria
Qualifiers
Diagnosed with idiopathic pulmonary fibrosis according to the 2018 guidelines of the American Thoracic Society/European Respiratory Society/Japanese Respiratory Society/Latin American Thoracic Association,
Diagnosed with IPF for at least 1 year,
Aged 18 years or older,
Able to express willingness and provide consent to participate in the study,
Disqualifiers
Diagnosed with dementia,
Unable to speak, read, or write in Italian,
Legally blind or deaf,
In advanced stage of disease (receiving oxygen therapy at 10 to 15 liters per minute).
Trial design
Treatments tested in this trial
- "motivational interviewing"